Search all trials

Find therapies in clinical trials near you – page 256

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Alopecia areata

Not recruiting

Registered drug

Study on Baricitinib for Treating Children Aged 6 to 17 with Alopecia Areata

Registered drug

Spain

Participants:0–17 years
Substances:Baricitinib

Contact Research Centre

Bronchiectasis

Not recruiting

Registered drug

Study on Long-Term Safety and Efficacy of BI 1291583 in Patients with Bronchiectasis

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Bi 1291583

Contact Research Centre

Microsatellite instability cancer+1

Not recruiting

Registered drugNo placebo

Study Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Favezelimab

Contact Research Centre

Renal cell carcinoma stage IV+1

Not recruiting

Registered drugNo placebo

Study Comparing Nivolumab and Ipilimumab with Sunitinib for Patients with Advanced or Metastatic Kidney Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Ipilimumab

Contact Research Centre

Glomerulonephritis membranoproliferative+1

Not recruiting

Registered drugNo placebo

Study on Long-term Safety and Efficacy of Pegcetacoplan for Patients with C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Pegcetacoplan

Contact Research Centre

Status epilepticus

Not recruiting

Investigational

Study on Ganaxolone for Patients with Refractory Status Epilepticus

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Ganaxolone

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Dostarlimab

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Registered drugNo placebo

Study on the Effects and Safety of Belimumab for Adults with Early Systemic Lupus Erythematosus

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Belimumab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study Comparing Patritumab Deruxtecan and Platinum-based Chemotherapy for Patients with Advanced EGFR-mutated Non-small Cell Lung Cancer After EGFR Therapy Failure

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Neoplasm

Not recruiting

Registered drugNo placebo

Study on the Safety and Tolerability of Olaparib in Children and Adolescents with Solid Tumors

Registered drugNo placebo

Spain

Participants:0–17 years
Substances:Olaparib

Contact Research Centre

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Not recruiting

Registered drugNo placebo

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Registered drugNo placebo

Spain

Participants:0–17 years
Substances:Alemtuzumab

Contact Research Centre

Dry age-related macular degeneration

Not recruiting

Registered drugNo placebo

Study on the Safety of Avacincaptad Pegol for Patients with Geographic Atrophy Who Completed a Previous Study

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Avacincaptad Pegol

Contact Research Centre

Find therapies in clinical trials near you – page 256

3 144 trials match your criteria

Alopecia areata

Study on Baricitinib for Treating Children Aged 6 to 17 with Alopecia Areata

Bronchiectasis

Study on Long-Term Safety and Efficacy of BI 1291583 in Patients with Bronchiectasis

Microsatellite instability cancer+1

Study Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency

Renal cell carcinoma stage IV+1

Study Comparing Nivolumab and Ipilimumab with Sunitinib for Patients with Advanced or Metastatic Kidney Cancer

Glomerulonephritis membranoproliferative+1

Study on Long-term Safety and Efficacy of Pegcetacoplan for Patients with C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

Status epilepticus

Study on Ganaxolone for Patients with Refractory Status Epilepticus

Non-small cell lung cancer

Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

Systemic lupus erythematosus

Study on the Effects and Safety of Belimumab for Adults with Early Systemic Lupus Erythematosus

Non-small cell lung cancer

Study Comparing Patritumab Deruxtecan and Platinum-based Chemotherapy for Patients with Advanced EGFR-mutated Non-small Cell Lung Cancer After EGFR Therapy Failure

Neoplasm

Study on the Safety and Tolerability of Olaparib in Children and Adolescents with Solid Tumors

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Dry age-related macular degeneration

Study on the Safety of Avacincaptad Pegol for Patients with Geographic Atrophy Who Completed a Previous Study

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.